Announcements

27 January 2025
Acknowledgment to the Reviewers of Diseases in 2024


The editorial team at Diseases extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, Diseases received 1879 review reports from 1246 reviewers representing 79 countries and regions worldwide.

To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, Diseases expresses its sincere gratitude through an annual acknowledgment of reviewers.

We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:

Astrida Velena Kielan Mcalinden
Afshan Masood Kijin Kim
Alejandra García-Gasca Konda Mani Saravanan
Alejandro Vega-Muñoz Konstantinos Efthymakis
Aleksandra Klisic Konstantinos Giakoumidakis
Alessandro Di Rienzo Koyeli Girigoswami
Alessia Verduri Krzysztof Korzeniewski
Alicia Irene Arechavala Kuldeep Gupta
Alireza Fakhriravari Kuo-Hui Su
Alireza Mohammad Karim Laurentiu M. Pop
Amirmohammad Khalaji Lidija Savić
Amit Goel Liliang Li
Ana Andabak Rogulj Lorenzo Malatino
Ana Hećimović Luca Giannella
Anastazia Kei Luca Giacomelli
Andrea Sonaglioni Lucia Ansani
Andreas Anestis Lukasz Szarpak
Andreas Müssigbrodt Lukasz Dobrek
Andreu Comas-Garcia Lyudmila Pivina
Andrew Jin Maciej Przybyłek
Angélica Saraí Jiménez-Osorio Maged Tharwat Elghannam
Angeliki Mavroidi Mahboob Alam
Angelos K. Sikalidis Makoto Endo
Anja Diem Marat Ezhov
Anna Alekseevna Skuredina Marc Beltrà
Anne Kasus-Jacobi Marcel Henrique Marcondes Sari
Anthony Fehr Marco Fiore
Anthony J. Sadler Marcus Krüger
Anton R. Kiselev Margarita Ivanova
Antonio Gidaro María Guadalupe Frías-De-León
Anuj Kumar Maria Kantzanou
Ariel Teles Maria Trovato
Arkalgud Ramaprasad Marino Paroli
Athanassios Tselebis Mario Diplomatico
Baihai Jiao Martine Wallon
Balakumar Chandrasekaran Marzena Jezewska-Zychowicz
Beatriz Teresita Martin Marquez Masoud Keikha
Bernardo Vega Crespo Massimo Montisci
Bernice N. Harris Mathieu David
Bill Primack Matteo Conti
Bin Du Matteo Riccò
Bojana B. Vidović Maximilian Deußing
Boleslaw Tomasz Karwowski Meng-Yao Li
Calin Cainap Michael Eisenhut
Carlos O'Connor-Reina Michał Zarobkiewicz
Carlos Trenado Mieszko Wieckiewicz
Catharina Sagita Moniaga Miguel A. Castro Villamor
Cesar Augusto Roque-Borda Mihai Capilna
Cesar Iván Avilés González Mihalj Poŝa
Chandrabose Selvaraj Milica Aćimović
Charikleia Stefanaki Mirjana Jerkic
Christian Wunder Mirza Pojskic
Christopher Kobierzycki Mohamed Rahouma
Claudiu N. Lungu Mohamed Abuzaid
Consolato Sergi Mohammadreza Shalbafan
Craig Horswill Muhammad Asif Zahoor
Cristian Mornos Myung Goo Lee
Cristina Capatina Narayanaswamy Venketasubramanian
Cyril Fersing Narsimha Mamidi
Daniela Braconi Natale Calomino
Daniele Ugo Tari Natale Musso
Danielle Greenberg Natalia Kamanina
Danijela Budimir Mršić Neeraj Kumar Chauhan
David A. Schwartz Negrut Nicoleta
Dee Wu Nenad Pandak
Delia Lidia Salaru Neus Baena
Demetrios Arvanitis Nicola Magnavita
Derar H. Abdel-Qader Nicola Nante
Dhruvesh Patel Nitin Sampat Kamble
Dia C. Beachboard Nompumelelo Mkhwanazi
Dimitris Tatsis Omid Mirmosayyeb
Dimosthenis Lykouras Omid Akhavan
Dirk W. Lachenmeier Ozgur Karcioglu
Doha Mohamed Panagiotis Savvoulidis
Dominika Guzek Paola Di Carlo
Dorota Formanowicz Paolo Monardo
Ebubekir Daglilar Paolo Landa
Edgar Flores-Soto Patrícia C. Pires
Eduardo Yoshio Nakano Patrick Martin
Eleuterio A. Sánchez-Romero Paweł Glibowski
Elias Kouroumalis Paweł Krzyżek
Elisabetta Tozzi Pedro Infante-Cossio
Emilia Migliano Peter Michael Baptista Jardin
Emiliano Tesoro-Cruz Peter Timmins
Emilio Bucio Petri Böckerman
Emmanouil Ioannis Kapetanakis Pietro Pugliatti
Erica Diani Primrose Freestone
Evangelos Liatsikos Puya Dehgani-Mobaraki
Evgeny N. Imyanitov Qingsen Shang
Fabio Fabbian Rafał Watrowski
Fabrizio Guerra Raghunadharao Digumarti
Farid Ahmed Rana A. Youness
Federica Fogacci Ravendra P. Chauhan
Federico Giorgi Renata Ciccarelli
Federico Marchesi Renata Heisler Neves
Fernando Ferrero Ren-Hau Li
Fernando P. Monroy Reza Nedaeinia
Flavia Leao Barbosa Richard F. Riedel
Flavia Mori Sarti Richard Honeywell
Flor H. Pujol Rishi Jaiswal
Flora De Conto Ritthideach Yorsaeng
Flora N. Balieva Robert Eibl
Francesco Massoni Robert Kleszcz
Francisco Epelde Roberta Di Pietro
Fumio Otsuka Roberto Castiglione
Fushan Tang Roberto Giovanni Carbone
Gang Li Roberto Scarpioni
George Koulaouzidis Roehe Michel Roehe
George Grant Ronit Vogt Sionov
Georgiana Bianca Constantin Roxana Liana Lucaciu
Gerard Goh Sagar Sudam Thorat
Ghulam Jilany Khan Sagarika Biswas
Gianluca Rizzo Said El-Ashker
Gilberto Gonzalez-Parra Salvatore Pezzino
Giovanni La Penna Sandeep Kumar Mishra
Giuliano Tocci Sandro Jose Ribeiro Bonatto
Giuseppe Di Martino Santiago Pedro Aubourg Martínez
Giuseppina Rea Satheesha B. Nayak
Godfrey Mutashambara Rwegerera Satoru Munakata
Gudrun Elisabeth Koehl Seamus O'Reilly
Guillermo Alberto Keller Semer Maksoud
Gulali Aktas Sergei Boichuk
Gustavo Fernandes Sergey Sedykh
Halim Işsever Seyed Ahmad Naseri Alavi
Halina Tkaczenko Shaher Hamaideh
Hamid Tebyaniyan Shalimar
Hamidreza Karimi-Sari Shaonong Dang
Harald Krentel Shehwaz Anwar
Henry Atkinson Shek Man Chim
Henry Lukaski Sherien Eldaly
Hitesh Chopra Shweta Tripathi
Hitoshi Tonomura Silvia Hofer
Hongmei Dong Simone Brogi
Hosoon Choi Singh Kumar Avishek
Hussam Ali Siyong Kim
Hwei Jene Ng Somya Agrawal
Ibrahim Gosadi Stefano Filippi
Ignazio Gaspare Vetrano Stefano Francesco Crinò
Ina Sevic Stephanie Dauth
Ioannis Ventoulis Subbarao V. Madhunapantula
Irena Ilic Sueli Fumie Yamada-Ogatta
Irina Vlasova-St. Louis Sulev Koks
Irma González-Curiel Sushant Covaris
Ivanildo Sousa Syed Nabil
Ivo Lopes Tadahisa Sugiura
James Patrick O'Connor Tajamul Hussain
Jacek Cholewicki Takemichi Fukasawa
Jacek Piątek Tania Colasanti
Jader De Oliveira Tarek M.A. Abdel-Fatah
Jaishree Raman Terenzio Cosio
Javier Martínez Torres Tetyana Chumachenko
Jean-Marie Exbrayat Tomislav Tosti
Jeni Prosperi Torbjörn Ledin
Jenna E. Coalson Ulf Schött
Jeremy Marks Ursula Panzner
Jia-Feng Chang Vaitsa Giannouli
Jialing Lin Vajir Malek
Jihua Guo Valentina Lancellotta
Jiří Remr Valerio Leoni
Joan-Lluis Vives Corrons Vance Nielsen
Joanna Dzido Vasiliki Karava
João Paulo Saraiva Santos Vasudevan Gowthaman
John K. Triantafillidis Víctor José González Ramallo
John Lalith Charles Richard Victoria Bunik
John P.A. Lusingu Vijay Patel
Jonathan Karp Vincent Ho
Jong-Hwa Jang Wei Boon Yap
Jorge Feito Wei-Ting Lin
Jose Martinez-Hernandez Wilhelm Peter Mistiaen
José Antonio De Paz Wing Shing Ho
José Artur Bogo Chies Wioletta Rozpędek-Kamińska
Jose-Luis Pérez-Castrillón Wissem Mnif
Josip Andelo Borovac Wladimir Bocca Vieira de Rezende Pinto
Juan Alberto Castillo-Garit Xian-Zhi Li
Juan Francisco Leon Yanka Dimitrova Karamalakova
Juan de los Toyos Yaoxiang Li
Juandy Jo Yasin Tülüce
Judy Gopal Yi-Qing Yang
Karel Van Den Bosch Yong Jin
Karen Bohmwald Yongbo Liang
Karolina Akinosoglou Yongsheng Chen
Katarina Sebekova Zehuan Liao
Katsuya Kitamura Zeljko Prijovic
Kay-Dietrich Wagner Zhenbo Xu
Kazuhiko Hashimoto Zhengwei Huang
Keita Kai Zhiwei Yang
Keith Rochfort Zoran Gluvic
Kenneth N. White Zoran Todorovic
Keren Dopelt Zornitsa Gancheva Kamenarska
 Khalid Muhammad

26 January 2025
World Neglected Tropical Diseases Day—30 January 2025


On 31 May 2021, the World Health Assembly (WHA) recognized 30 January as World Neglected Tropical Disease (NTD) Day. This decision formalized 30 January as a day to create better awareness on the devastating impact of NTDs on the poorest populations around the world. The day is also an opportunity to call on everyone to support the growing momentum for the control, elimination and eradication of these diseases.

We would like to recommend some related articles, Special Issues, and journals in the field of medicine & pharmacology as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of NTDs.

   

A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System
by Christina Alexopoulou, Athanasia Proklou, Sofia Kokkini, Maria Raissaki, Ioannis Konstantinou and Eumorfia Kondili
Healthcare 2024, 12(5), 568; https://doi.org/10.3390/healthcare12050568

Evaluation of an Artificial Intelligence-Based Tool and a Universal Low-Cost Robotized Microscope for the Automated Diagnosis of Malaria
by Carles Rubio Maturana, Allisson Dantas de Oliveira, Francesc Zarzuela, Alejandro Mediavilla, Patricia Martínez-Vallejo, Aroa Silgado, Lidia Goterris, Marc Muixí, Alberto Abelló, Anna Veiga et al.
Int. J. Environ. Res. Public Health 2025, 22(1), 47; https://doi.org/10.3390/ijerph22010047

Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview
by Maria Letizia Giancola, Andrea Angheben, Laura Scorzolini, Stefania Carrara, Ada Petrone, Antonella Vulcano, Raffaella Lionetti, Angela Corpolongo, Rosalia Marrone, Francesca Faraglia et al.
Infect. Dis. Rep. 2024, 16(4), 650-663; https://doi.org/10.3390/idr16040050

Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review
by Gifty Osei Berchie, Patience Fakornam Doe, Theodora Dedo Azu, Joyce Agyeiwaa, Gifty Owusu, Christian Makafui Boso, Naomi Kyeremaa Yeboa, Dorcas Frempomaa Agyare, Irene Korkoi Aboh, Bernard Nabe et al.
Diseases 2024, 12(9), 203; https://doi.org/10.3390/diseases12090203

Laparoscopic Management of Multiple Liver, Omental, Mesenteric, Peritoneal, and Round Ligament Hydatid Cysts—A Rare Report of a Case and a Systematic Literature Review
by Alin Mihetiu, Dan Georgian Bratu, Ciprian Tanasescu, Bogdan Ioan Vintilă, Alexandra Sandu, Mariana Sandu, Dragos Serban, Dan Sabau and Adrian Hasegan
J. Pers. Med. 2024, 14(2), 205; https://doi.org/10.3390/jpm14020205

False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report
by Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph and Andrea K. Boggild
Reports 2024, 7(4), 100; https://doi.org/10.3390/reports7040100

Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks
by Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Shohei Iida, Habe Koji and Keiichi Yamanaka
Clin. Pract. 2023, 13(1), 246-250; https://doi.org/10.3390/clinpract13010022

Oral Chagas Disease in Colombia—Confirmed and Suspected Routes of Transmission
by Norman L. Beatty, Catalina Arango-Ferreira, Lídia Gual-Gonzalez, Sara Zuluaga, Melissa S. Nolan and Omar Cantillo-Barraza
Trop. Med. Infect. Dis. 2024, 9(1), 14; https://doi.org/10.3390/tropicalmed9010014

Global Patterns of Trends in Incidence and Mortality of Dengue, 1990–2019: An Analysis Based on the Global Burden of Disease Study
by Irena Ilic and Milena Ilic
Medicina 2024, 60(3), 425; https://doi.org/10.3390/medicina60030425

DengueFog: A Fog Computing-Enabled Weighted Random Forest-Based Smart Health Monitoring System for Automatic Dengue Prediction
by Ashima Kukkar, Yugal Kumar, Jasminder Kaur Sandhu, Manjit Kaur, Tarandeep Singh Walia and Mohammed Amoon
Diagnostics 2024, 14(6), 624; https://doi.org/10.3390/diagnostics14060624

Global Fight against Malaria: Goals and Achievements 1900–2022
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680

Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil
by Raquel Curtinhas de Lima, Helver Gonçalves Dias, Thiara Manuele Alves de Souza, Débora Familiar-Macedo, Edcelha D’Athaide Ribeiro, Valmir Corrêa e Corrêa, Alex Pauvolid-Corrêa, Elzinandes Leal de Azeredo and Flávia Barreto dos Santos
Pathogens 2024, 13(6), 469; https://doi.org/10.3390/pathogens13060469

Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128

Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective
by Carlos F. M.Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. Silva
Pharmaceuticals 2024, 17(3), 285; https://doi.org/10.3390/ph17030285

Prevalence of Intestinal Parasites, Protozoans and Soil-Transmitted Helminths, in Children from Communities of Northern Argentina after the Interruption of Deworming
by Ernesto Candela, Rubén O. Cimino, Leonardo Sandon, Carla Muñoz-Antoli and María Victoria Periago
Parasitologia 2024, 4(2), 172-183; https://doi.org/10.3390/parasitologia4020015

Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant Leishmania
by Sehyeon (Erica) Kim, Ana Victoria Ibarra-Meneses, Christopher Fernandez-Prada and Tao Huan
Metabolites 2024, 14(12), 658; https://doi.org/10.3390/metabo14120658

Special Issue: “Infectious Disease Prevention and Public Health Promotion: Second Edition

Special Issue: “Advances in Molecular Diagnosis in Neglected Tropical Diseases

Special Issue: “One Health and Neglected Zoonotic Diseases

Special Issue: “Dysbiosis and Metabolic Disorders of the Microbiota

26 January 2025
Meet Us at the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery, 20–22 February 2025, Yamaguchi, Japan


Conference:
The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery
Date: 20–22 February 2025
Location:
Yamaguchi, Japan

MDPI will be attending the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery as an exhibitor which will be held from 20 to 22 February 2025. We invite researchers from different fields of study to share their ideas with us.

The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery will be held in Shimonoseki. The theme of the annual meeting is “Beyond The WAVE! Go on and overcome!”. This meeting theme aims to help surgeons overcome difficulties and challenges during their growth and development. The entire meeting will be split into five areas of coronary artery disease—valvulopathy, aortic disease, congenital malformations, and peripheral vascular disease—each of which has its own Program Committee that has put together the primary sessions. Attending the meeting is important for academic learning at the venue, but exchanging views with other participants, obtaining new information, and engaging in conversations is also extremely meaningful.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to visit booth #27 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. We warmly encourage researchers from different backgrounds to visit and share their ideas with us.

For more information about the conference, please visit the following website: https://www.congre.co.jp/jscvs2025/en/index.html.

24 January 2025
World Leprosy Day 2025—Unite. Act. Eliminate.


World Leprosy Day is a global awareness initiative aimed at shedding light on the ongoing challenges posed by leprosy, a curable disease that still affects thousands annually. This day also emphasizes the collective responsibility to eliminate stigma, promote dignity, and ensure equitable access to healthcare for individuals and communities impacted by leprosy. It serves as a reminder of the importance of early detection, effective treatment, and global cooperation in addressing this neglected tropical disease.

In recognition of World Leprosy Day 2025, we invite you to explore selected articles, Special Issues, and journals such as Pathogens, Microbiology Research, Diseases, Healthcare and Tropical Medicine and Infectious Disease. By fostering collaboration and sharing knowledge, we aim to inspire positive action and contribute to a future where leprosy is no longer a public health concern, and all individuals affected by it can live with dignity and acceptance.

 

The Safety, Acceptability, and Feasibility of Single-Dose Rifampicin as Post-Exposure Chemoprophylaxis for Contacts of Leprosy Patients in Togo: A Mixed-Method Sequential Explanatory Study
by Akila Wimima Bakoubayi, Falapalaki Haliba, Wendpouiré Ida C. Zida-Compaore, P’tanam P’kontème Bando, Yao Rodion Konu, Abissouwèssim Egbare Tchade, Kodjo Akpadja, Kamevor Alaglo, Maweke Tchalim, P’niwè Patchali et al.
Trop. Med. Infect. Dis. 2024, 9(11), 276; https://doi.org/10.3390/tropicalmed9110276

Genomic and Phenotypic Variations Among Thai-53 and Mycobacterium leprae Clinical Isolates: Implications for Leprosy Pathogenesis and Research
by Tiago Araujo Gomes, Tatiana Pereira da Silva, Edson Machado, Sidra Ezidio Gonçalves Vasconcelos, Bruno Siqueira Mietto, Daniela Ferreira de Faria Bertoluci, Patricia Sammarco Rosa, Roberta Olmo Pinheiro, Philip Noel Suffys, Letícia Miranda Santos Lery et al.
Pathogens 2024, 13(11), 986; https://doi.org/10.3390/pathogens13110986

Human Skin as an Ex Vivo Model for Maintaining Mycobacterium leprae and Leprosy Studies
by Natália Aparecida de Paula, Marcel Nani Leite, Daniele Ferreira de Faria Bertoluci, Cleverson Teixeira Soares, Patrícia Sammarco Rosa and Marco Andrey Cipriani Frade
Trop. Med. Infect. Dis. 2024, 9(6), 135; https://doi.org/10.3390/tropicalmed9060135

Training and Active Case Detection to Prevent Leprosy: Effect on Knowledge, Attitude and Skills of Health Workers on Early Diagnosis of Leprosy in a Leprosy Hotspot District in Ethiopia
by Ephrem Mamo, Dareskedar Tsehay, Seid Hassen, Solomon Getahun, Addis Mengiste, Beletshachew Tadesse, Tesfaye Tadesse, Mengestu Legesse and Kidist Bobosha
Trop. Med. Infect. Dis. 2024, 9(3), 51; https://doi.org/10.3390/tropicalmed9030051

Self-Care Ability and Life Quality of Cured Leprosy Patients: The Mediating Effects of Social Support
by Li Xu, Guangjie Jin, Xiang Li, Yuting Shao,Yunhui Li and Lianhua Zhang
Healthcare 2023, 11(23), 3059; https://doi.org/10.3390/healthcare11233059

Immunohistochemical Characterization of M1, M2, and M4 Macrophages in Leprosy Skin Lesions”
by Tatiane Costa Quaresma, Lívia de Aguiar Valentim, Jorge Rodrigues de Sousa, Tinara Leila de Souza Aarão, Hellen Thais Fuzii, Maria Irma Seixas Duarte, Juarez de Souza and Juarez Antônio Simões Quaresma
Pathogens 2023, 12(10), 1225; https://doi.org/10.3390/pathogens12101225

Potassium-Incorporated Titanium Oxide Nanoparticles Modulate Human Dendritic Cell Immune Response to Mycobacterium leprae
by Sam Warren, So Yoon Lee, Jose Barraga, Piya Kositangool, Hatsuko Yoshikubo and Jorge Cervantes
Microbiol. Res. 2023, 14(2), 787-797; https://doi.org/10.3390/microbiolres14020055

Meaningful Engagement of Persons Affected by Leprosy in Research: An Exploration of Its Interpretation, Barriers, and Opportunities
by Laura de Groot, Anna T. van ‘t Noordende, Mathias Duck, Joshua Oraga, Sarju Sing Rai, Ruth M. H. Peters and Nienke Veldhuijzen
Trop. Med. Infect. Dis. 2023, 8(1), 52; https://doi.org/10.3390/tropicalmed8010052

Infectious Disease Prevention and Public Health Promotion: Second Edition

Towards Zero Leprosy: Epidemiology and Prevention Strategy

Epidemiological Trends and Risk Factors in Geriatric and Infectious Diseases

Advances in Molecular Diagnosis in Neglected Tropical Diseases

22 January 2025
Meet Us at the 102nd Annual Meeting for the Osaka Society for Dialysis Therapy, 2 March 2025, Osaka, Japan


Conference: The 102nd Annual Meeting for the Osaka Society for Dialysis Therapy
Date: 2 March 2025
Location: Osaka, Japan

MDPI will be attending the 102nd Annual Meeting for the Osaka Society for Dialysis Therapy, which will be held on 2 March 2025, as an exhibitor, and we welcome researchers from various backgrounds to visit and share their latest ideas with us.

In the future, it is expected that the introduction of generative AI, IoT, and robotics will enhance medical services, expand and strengthen research support systems, and further improve medical technologies. The Osaka Dialysis Research Society has the mission of achieving sustainable development in the fields of dialysis and chronic kidney disease treatment, thereby improving the quality of life (QOL) and prognosis of patients undergoing dialysis and those with chronic kidney disease. To fulfill this mission, they aim to strive for the introduction of the latest research and technologies in dialysis therapy and chronic kidney disease treatment, as well as the education, professional development, and training of medical practitioners.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://osdt.jp/102th/.

21 January 2025
MDPI’s Newly Launched Journals in December 2024

Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)


Prof. Dr. Zhaoyang Dong
City University of Hong Kong, China
Editorial | View inaugural issue

energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage
View journal scope | Submit an article

Prof. Dr. Yang-Hui He
1. London Institute for Mathematical Sciences, Royal Institution, UK
2. University of Oxford, UK
Editorial | View inaugural issue
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory;  convex geometry
View journal scope | Submit an article

Dr. Michel Planat
Université de Franche-Comté, France
Editorial | View inaugural issue
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets
View journal scope | Submit an article

Prof. Dr. Rashid Al Abri
1. Sultan Qaboos University, Oman
2. Oman Medical Association, Oman
Editorial | View inaugural issue
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety
View journal scope | Submit an article

Prof. Dr. Ecevit Bilgili*
New Jersey Institute of Technology, USA
*Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration.
Editorial | View inaugural issue
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production
View journal scope | Submit an article

Dr. Weiyong Liu
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry
View journal scope | Submit an article

Prof. Dr. Manuel Pedro Rodríguez Bolívar
University of Granada, Spain
Editorial | View inaugural issue
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation
View journal scope | Submit an article

Prof. Dr. Fei Fan
Wuhan University, Wuhan 430072, China
Editorial | View inaugural issue
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice
View journal scope | Submit an article

Dr. Kevin Cianfaglione
Université Catholique de Lille, France
Editorial | View inaugural issue
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation
View journal scope | Submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee ([email protected]) if you would like to create more new journals.

17 January 2025
Meet Us at the 145th Annual Meeting of the Pharmaceutical Society of Japan, 26–29 March 2025, Fukuoka, Japan


Conference:
The 145th Annual Meeting of the Pharmaceutical Society of Japan
Date: 26–29 March 2025
Location: Fukuoka, Japan

MDPI will be attending the 145th Annual Meeting of the Pharmaceutical Society of Japan as an exhibitor, which will be held from 26 to 29 March 2025, and we welcome researchers from diverse backgrounds to visit and share their latest ideas with us.

The conference is organized by the Pharmaceutical Society of Japan and chaired by Prof. Takashi Ohshima from the Graduate School of Pharmaceutical Sciences, Kyushu University. The theme is Promoting the Ecosystem in Pharmaceutical Sciences: Future Innovation through Cross-disciplinary Collaboration. This conference will bring together around 5,000 scientists and students to share research advances covering a wide range of scientific topics. The sessions include, but are not limited to, the following: 1) Pharmaceutical Chemistry; 2) Pharmaceutical Physics; 3) Pharmaceutical Biology; 4) Pharmaceutical Health Science and Environmental Toxicology; 5) Pharmaceutical Health Care and Sciences; and 6) Others.

The following MDPI journals will be represented at the conference:

  • Biomedicines
  • Pharmaceuticals
  • Pharmaceutics
  • Antibiotics
  • Antibodies
  • Antioxidants
  • CIMB
  • Diseases
  • Future Pharmacology
  • IJERPH
  • IJMS
  • IJTM
  • JNT
  • JPM
  • Marine Drugs
  • Medicina
  • Medicines
  • Metabolites
  • Psychoactives
  • Sci. Pharm
  • Sclerosis

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://pub.confit.atlas.jp/en/event/pharm145.

15 January 2025
Meet Us Virtually at the 1st International Online Conference on Diseases—From the Molecular to the Clinical Perspectives, 9–11 September 2025


Name:
The 1st International Online Conference on Diseases
Date: 9–11 September 2025
Chair: Prof. Dr. Omar Cauli, University of Valencia, Department of Nursing, Spain

We are pleased to announce that the 1st International Online Conference on Diseases, chaired by Prof. Dr. Omar Cauli, will be held from 9 to 11 September 2025.

This conference aims to provide leading scientists working in the field of diseases, from the molecular to the clinical perspective, with a robust common platform through which to share and discuss the latest research and to promote the advancement of this exciting and rapidly changing field.

We hope to encourage discovery across the discipline as we cover the following themes:
S1: Infectious diseases;
S2: Nutrition and dietetics;
S3: Immune and inflammatory diseases;
S4: Geriatrics;
S5: Cardiovascular diseases;
S6: Neuropsychiatric disorders;
S7: Endocrine and metabolic disorders.

Important Deadlines:
Deadline for abstract submission: 12 May 2025;
Notification of acceptance: 23 June 2025;
Deadline for registration: 4 September 2025.

Guide for Authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1297
To register for the event for free, please click on the following link: https://sciforum.net/event/IOCD2025?section=#registration.

For more information, you may refer to https://sciforum.net/event/IOCD2025?section=#instructions.

For any enquiries regarding the event, please contact us at [email protected].

We look forward to seeing you at the 1st International Online Conference on Diseases!

7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflecting on 2024: Celebrating Our Progress and People

As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.

Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.

Looking for a new role in 2025? We have a variety of roles currently open!

Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.

These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.

On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.

Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.

“MDPI thrives because of community and collaboration”

When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.

As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.

Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.

PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.

Impactful Research

685 MDPI Editors Named Highly Cited Researchers in 2024

I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.

Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.

Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.

As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.

I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.

Inside MDPI

How MDPI / Open Access Supports Societies

MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.

Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.

Learn about how MDPI / Open Access Supports Societies.

In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.

If you would like to learn more about these services, please see the Societies website.

The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.

How long have you been at MDPI, and what was your first role?

I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team. 

Do you think that perceptions of Open Access are generally accurate?

Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards. 

How long have you been at MDPI, and what was your first role?

I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.

What is the most common question you get asked about the services that the Societies team provides?

For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.  

For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.

Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.

Read more:

Coming Together for Science

2024 MDPI Conference Summary

Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.

The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.

2024 Event Highlights

Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.

Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’

Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’

A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.

The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.

ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.

The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.

Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.

In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.

The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.

Scheduled Events in 2025

Closing Thoughts

Over 100 German Universities Partner with MDPI in New National Agreement  

I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.

This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.

Learn more, here.

“Thank you to everyone who contributed to making this agreement a reality.”

Why is this important?

Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.

This agreement reflects our growing influence and leadership in open access publishing.

Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.

As Peter Roth, MDPI Head of Publishing, noted:

“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.” 

Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:

“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform” 

Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.

Stefan Tochev
Chief Executive Officer
MDPI AG

6 January 2025
Meet Us at the ESCMID Global 2025, 11–15 April 2025, Vienna, Austria


MDPI will attend ESCMID Global 2025, which will take place in Vienna, Austria, from 11 April to 15 April 2025.

ESCMID Global is the largest international meeting of its kind, and it plays a pivotal role in bringing together the global scientific community to exchange knowledge, share insights, and collaborate on cutting-edge research. Last year, the conference attracted 18,599 registered participants and received more than 7,800 abstract submissions from more than 129 countries. This overwhelming response underscores the ongoing growth of the ESCMID Global community and its leadership role in the field of infections. The submissions covered a wide range of topics and allowed for the curation of an outstanding and diverse programme that showcased the latest research and innovations from leading experts in the field.

The following MDPI journals will be represented at the conference:

If you are planning on attending this conference, please do not hesitate to stop by our booth, K40, and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escmid.org/congress-events/escmid-global/vienna-2025/.

Back to TopTop